For citations:

Kurbatov D.G., Galstyan G.R., Shvarts Yu.G., Rozhivanov R.V., Dubskiy S.A., Lepetukhin A.E. Evaluating of the phosphodiesterase inhibitor type 5 effectiveness in treatment of neurogenic erectile dysfunction in patients with DM type 1. Problems of Endocrinology. 2015;61(4):24-28. https://doi.org/10.14341/probl201561424-28